Primary Sclerosing Cholangitis: Gender Effects in Valencia’s Low-Prevalence Region
Digestive Diseases and Sciences · 2024
DOI: 10.1007/s10620-024-08368-y ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Digestive Diseases and Sciences, 2024. Verfasst von Alejandro Mínguez und 12 weiteren Autor:innen. Beteiligte Einrichtung: Universitary and Politecnic Hospital La Fe, 46007, Valencia, CP, Spain. alejandromsab11@gmail.com. Hauptthemen laut MEDLINE: Cholangitis, Sclerosing. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND AND AIMS: Recent studies point out to epidemiological changes in primary sclerosing cholangitis (PSC). Our aims were to determine in PSC patients followed in several centers in a Mediterranean geographic area: (i) changes in baseline features and (ii) effect of gender on clinical course. METHODS: Retrospective multicenter study of PSC patients treated in 8 hospitals in a Mediterranean area between 2000 and 2021. Charts were reviewed compiling demographic, clinical, radiological, and histological variables. RESULTS: Cohort of 112 PSC patients included, 42% women, 70% diagnosed after 2010. Women were increasingly diagnosed in recent cohorts. The median time from diagnosis to the combined endpoint liver transplantation (Lt) and/or death was 6.9 years. Asthenia at diagnosis (p = 0.009) was associated with lower transplant-free survival, while diagnosis before 2005 was associated with greater LT-free survival (p < 0.001). By Cox regression, LT-free survival was not influenced by age, sex, or cirrhosis at the time of diagnosis. Women were found to have less jaundice at diagnosis (2 vs 14%; p = 0.013), higher prevalence of ANA antibodies (43.9 vs 15.7%; p = 0.003), and lower GGT levels at diagnosis (GGT 123 vs 209U/L; p = 0.014) than men. CONCLUSION: In an area traditionally considered to have low prevalence, the prevalence of affected women surpasses expectations based on existing literature. There appear to be gender-related variations in the presentation of the condition, highlighting the need for confirmation through larger-scale studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Universitary and Politecnic Hospital La Fe, 46007, Valencia, CP, Spain. alejandromsab11@gmail.com.
- Universitary and Politecnic Hospital La Fe, 46007, Valencia, CP, Spain.
- Hepatology and Liver Transplant Unit, IIS La Fe & CIBER-EHD, Universitary and Politecnic Hospital La Fe, Valencia, Spain.
- Digestive Disease Department, Clinic University Hospital, INCLIVA Health Research Institute, 46410, Valencia, Spain.
- General University Hospital of Valencia, Valencia, Spain.
- Hepatology and Liver Transplant Unit/HGU Dr. Balmis, Alicante, Spain.
Zitieren
APA
Mínguez, A., Conde, I., Montón, C., Gonzalez, L., Pascual, S., Antón, M. D., Palau, A., Forés, A., Gisbert, C., Ojeda, A., Girona, E., Di Maira, T., & Berenguer, M. (2024). Primary Sclerosing Cholangitis: Gender Effects in Valencia’s Low-Prevalence Region. Digestive Diseases and Sciences. https://doi.org/10.1007/s10620-024-08368-y
Vancouver
Mínguez A, Conde I, Montón C, Gonzalez L, Pascual S, Antón MD, et al. Primary Sclerosing Cholangitis: Gender Effects in Valencia’s Low-Prevalence Region. Digestive Diseases and Sciences. 2024. doi:10.1007/s10620-024-08368-y
BibTeX
@article{Mnguez2024,
author = {Mínguez, Alejandro and Conde, Isabel and Montón, Cristina and Gonzalez, Lara and Pascual, Sonia and Antón, María Dolores and Palau, Antonio and Forés, Ana and Gisbert, Concha and Ojeda, Asunción and Girona, Eva and Di Maira, Tommaso and Berenguer, Marina},
title = {Primary Sclerosing Cholangitis: Gender Effects in Valencia’s Low-Prevalence Region},
journal = {Digestive Diseases and Sciences},
year = {2024},
doi = {10.1007/s10620-024-08368-y}
}
EUVIMED